Results 1 to 10 of about 63,957 (248)

Tricuspid valve papillary fibroelastoma in an adult patient: a case report and review of literature [PDF]

open access: yesJournal of Cardiothoracic Surgery
Background Tricuspid valve papillary fibroelastoma is a rare, benign primary cardiac tumor located on the tricuspid valve, with a potential risk of embolism.
Zhenchun Ji   +7 more
doaj   +2 more sources

Tricuspid valve replacement provides better long-term survival and tricuspid valve function than repair in patients with systemic right ventricleCentral MessagePerspective

open access: yesJTCVS Open, 2023
Objective: The purpose of this study is to compare the long-term outcomes of 2 different tricuspid surgeries including valvuloplasty and replacement for significant tricuspid regurgitation in patients with systemic right ventricle.
Akihisa Furuta, MD, PhD   +4 more
doaj   +1 more source

Comparative outcomes and risk analysis after cone repair or tricuspid valve replacement for Ebstein's anomalyCentral MessagePerspective

open access: yesJTCVS Open, 2023
Objective: Ebstein's anomaly is a rare congenital heart malformation for which surgical and medical management are still controversial. The cone repair has transformed surgical outcomes in many of these patients.
Rebekah Boyd, MD   +9 more
doaj   +1 more source

Transcatheter Tricuspid Valve-in-Valve Replacement Using a J-Valve System for a Failed Tricuspid Bioprosthesis

open access: yesCase Reports in Cardiology, 2022
Background. Redo operation for failed tricuspid bioprosthetic valves is associated with high morbidity and mortality. Transcatheter tricuspid valve-in-valve implantation has become an acceptable option for high-risk patients with a failed tricuspid ...
Mingkui Zhang   +4 more
doaj   +1 more source

Update on Transcatheter Tricuspid Valve Replacement Therapies

open access: yesFrontiers in Cardiovascular Medicine, 2021
Severe tricuspid regurgitation is relatively common, especially in the elderly, and portends poor survival. Neither medical therapy nor conventional surgery is efficacious for most patients.
Ythan H. Goldberg   +3 more
doaj   +1 more source

Tricuspid valve endocarditis [PDF]

open access: yesAnnals of Cardiothoracic Surgery, 2019
Right-sided infective endocarditis (RSIE) encompasses 5–10% of all infective endocarditis (IE) cases. Among them, about 90% involve the tricuspid valve (TV) (1). Major risk factors for TV infective endocarditis (TVIE) are intravenous drug use, pacemaker (PM) leads and indwelling vascular accesses (1,2). Only between 5–16% of RSIE cases require surgical
Mateo, Marin-Cuartas   +3 more
openaire   +2 more sources

Right sided heart evaluation after successful mitral valve replacement. [PDF]

open access: yesJournal of Cardio-Thoracic Medicine, 2019
Introduction: It is well-documented that right-sided heart dysfunction and significant tricuspid valve regurgitation (TVR) have adverse effects on patient outcomes after left-sided heart valve surgery. Therefore, the evaluation of right ventriclular (RV)
Hedieh Alimi   +3 more
doaj   +1 more source

Transcatheter Double Valve Replacement to Treat Aortic Stenosis and Severe Tricuspid Regurgitation with 3D Printing Guidance after Mechanical Mitral Valve Replacement

open access: yesJournal of Cardiovascular Development and Disease, 2022
Background: Transcatheter treatments of tricuspid regurgitation (TR) have been emerging as alternatives for high-risk patients. In contrast to the immobilization of the common transcatheter tricuspid device, using a radial force-independent stent valve ...
Mengen Zhai   +4 more
doaj   +1 more source

Three-dimensional echocardiography of the tricuspid valve

open access: yesFrontiers in Cardiovascular Medicine, 2023
Due to the proportionally high mortality rates associated with isolated tricuspid valve surgery, the invasive treatment of such pathology, historically, has been left largely unaddressed.
Zachary T. Jost   +4 more
doaj   +1 more source

Percutaneous Tricuspid Valve Repair

open access: yesReviews in Cardiovascular Medicine, 2022
Tricuspid regurgitation (TR) negatively affects patient outcomes. Surgical tricuspid valve repair/replacement carries a high operative risk and is not a viable option for many high-risk patients. Percutaneous approaches provide an attractive alternative solution for such patients since they represent a valid alternative to open heart surgery without ...
Mangieri A   +13 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy